Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The "big girl" Who Shrunk into a Baby.
Bender HU. Bender HU. J Palliat Med. 2023 May;26(5):733. doi: 10.1089/jpm.2023.0065. J Palliat Med. 2023. PMID: 37130288 Free article. No abstract available.
Eight Minutes.
Bender HU. Bender HU. J Palliat Med. 2019 May;22(5):597. doi: 10.1089/jpm.2018.0388. J Palliat Med. 2019. PMID: 31063453 No abstract available.
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Juergens H, Kolb HJ, Burdach SE. Thiel U, et al. Among authors: bender hu. Oncotarget. 2016 Oct 25;7(43):70959-70968. doi: 10.18632/oncotarget.10938. Oncotarget. 2016. PMID: 27486822 Free PMC article.
A big pot of colored sweets.
Bender HU. Bender HU. J Palliat Med. 2015 Mar;18(3):305. doi: 10.1089/jpm.2014.0282. Epub 2015 Feb 11. J Palliat Med. 2015. PMID: 25671349 No abstract available.
Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation.
Reinwald M, Schleyer E, Kiewe P, Blau IW, Burmeister T, Pursche S, Neumann M, Notter M, Thiel E, Hofmann WK, Kolb HJ, Burdach S, Bender HU. Reinwald M, et al. Among authors: bender hu. Biomed Res Int. 2014;2014:637059. doi: 10.1155/2014/637059. Epub 2014 Jun 15. Biomed Res Int. 2014. PMID: 25025064 Free PMC article. Clinical Trial.
17 results